T2 Biosystems
Update in progressTTOO (OTC Markets OTCPK)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
T2 Biosystems, Inc. develops and commercializes diagnostic tests for critical unmet health needs. Its portfolio includes the T2Dx instrument, the T2Candida panel, and the T2Bacteria panel, designed for rapid, direct-from-blood testing. Founded in 2006, the company is based in Lexington, Massachusetts. T2 Biosystems focuses on improving infection diagnosis and patient outcomes through rapid, actionable results.
Company score
- Sentiment
- -0.53
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.61
- Governance
- -0.25
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.24
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.38
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!